ORLANDO -- Postmenopausal women using hormone therapy (HT) saw significantly greater weight loss while taking the dual GIP/GLP-1 receptor agonist tirzepatide than their counterparts not using HT, ...

NEW ORLEANS — Many of us who have tried to lose weight have been told we're just not trying hard enough. And for women after menopause, the newest study suggests it may be something completely out of ...

Some women are experiencing significant hair loss as a side effect of testosterone therapy and popular weight-loss drugs. Rapid weight loss from GLP-1 medications like Ozempic and Zepbound can trigger ...

The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal ...

Preclinical data suggest a possible synergistic interaction between estrogen and GLP-1 signaling, explains Regina Castaneda, MD. Midlife weight gain is a persistent challenge for many women, but ...

If you find that you’re not losing weight on Ozempic or other GLP-1 medications, your metabolism, or how quickly your body burns calories, may be the cause. It’s sometimes called the “Ozempic plateau, ...